ETON PHARMACEUTICALS INC (ETON) Stock Balance Sheet
USA - NASDAQ:ETON - US29772L1089 - Common Stock
17.45 USD
-0.01 (-0.06%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 25.38M | 14.94M | 21.39M | 16.31M | 14.41M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 14.45M | 5.36M | 3.41M | 1.85M | 5.47M | |||
| Inventories | 23.79M | 15.23M | 911.00K | 560.00K | 550.00K | |||
| Other Current Assets | 4.82M | 5.49M | 1.13M | 1.29M | 3.18M | |||
| Total Current Assets | 68.44M | 41.02M | 26.84M | 20.00M | 23.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 342.00K | 209.00K | 150.00K | 260.00K | 220.00K | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | 32.88M | 34.88M | 4.74M | 4.75M | 3.62M | |||
| Other Non-Current Assets | 12.00K | 12.00K | 12.00K | 10.00K | 20.00K | |||
| Total Non-Current Assets | 33.23M | 35.10M | 4.90M | 5.03M | 3.87M | |||
| TOTAL ASSETS | 101.68M | 76.12M | 31.74M | 25.03M | 27.47M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 2.77M | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | 0 | 5.38M | 1.03M | 1.42M | |||
| Accrued Expenses | 23.68M | 15.78M | 9.01M | 3.74M | 1.37M | |||
| Accounts Payable | 12.14M | 4.17M | 1.85M | 1.69M | 1.77M | |||
| Other Current Liabilities | null | null | null | null | null | |||
| Total Current Liabilities | 38.60M | 19.95M | 16.24M | 6.46M | 4.56M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 27.41M | 29.81M | 0 | 5.38M | 5.26M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 11.71M | 1.94M | 22.00K | 110.00K | 20.00K | |||
| Total Non-Current Liabilities | 39.12M | 31.75M | 22.00K | 5.49M | 5.28M | |||
| TOTAL LIABILITIES | 77.72M | 51.70M | 16.26M | 11.95M | 9.84M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -112.05M | -107.89M | -104.07M | -103.13M | -94.11M | |||
| Additional Paid In Capital | 135.98M | 132.29M | 119.52M | 116.19M | 111.72M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 27.00K | 27.00K | 26.00K | 30.00K | 30.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | null | null | null | null | |||
| Shares Outstanding | 26.82M | 26.71M | 25.69M | 25.35M | 24.63M | |||
| Tangible Book Value per Share | -0.3325 | -0.3914 | 0.418 | 0.3286 | 0.5688 | |||
| Total Shareholders' Equity | 23.96M | 24.43M | 15.48M | 13.08M | 17.63M | |||
| TOTAL LIABILITIES AND EQUITY | 101.68M | 76.12M | 31.74M | 25.03M | 27.47M | |||
| Statistics | ||||||||
| Debt/Equity | 1.26 | 1.22 | N/A | 0.41 | 0.30 | |||
| Current Ratio | 1.77 | 2.06 | 1.65 | 3.10 | 5.18 | |||
| Return On Assets (ROA) | -4.06% | -5.02% | -2.95% | -36.04% | -7.14% | |||
| Return On Equity (ROE) | -17.23% | -15.65% | -6.05% | -68.96% | -11.12% | |||
All data in USD , ROIC based on taxRate of 0.21